Click Here for 5% Off Your First Aladdin Purchase!

PFE-360 - 98%, high purity , CAS No.1527475-61-1

  • ≥98%
Item Number
P649165
Grouped product items
SKUSizeAvailabilityPrice Qty
P649165-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$210.90
P649165-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$290.90
P649165-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$590.90
P649165-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$950.90
P649165-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,500.90
View related series
Autophagy LRRK2

Basic Description

Specifications & Purity98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
Product Description

PFE-360 (PF-06685360) is a potent, selective, brain penetrated and orally active leucine-rich repeat kinase 2 (LRRK2) inhibitor with a mean IC 50 of 2.3 nM in vivo

In Vivo

PFE-360 (4 mg/kg and 7.5 mg/kg, orally, BID, 10-12 weeks) treatment potently decreases the LRRK2-pSer935/total LRRK2 ratio, with no significant adverse effects . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female Sprague Dawley rats (NTac:SD) weighed 225-250 g. Dosage: 4 mg/kg and 7.5 mg/kg ( pharmacokinetics and pharmacodynamics ). Administration: Orally BID for 10-12 weeks. Result: The LRRK2-pSer935/total LRRK2 ratio was significantly decreased at both 1 h and 12 h after dosing. The terminal bodyweights exhibited no significant changes.

Form:Solid

IC50& Target:IC50: 2.3 nM (LRRK2 in vivo)

Associated Targets

LRRK2 Tchem Leucine-rich repeat serine/threonine-protein kinase 2 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 1-methyl-4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)pyrrole-2-carbonitrile
INCHI InChI=1S/C16H16N6O/c1-21-9-11(6-12(21)7-17)13-8-18-15-14(13)16(20-10-19-15)22-2-4-23-5-3-22/h6,8-10H,2-5H2,1H3,(H,18,19,20)
InChi Key IYQTYHISVSPMSU-UHFFFAOYSA-N
Canonical SMILES CN1C=C(C=C1C#N)C2=CNC3=C2C(=NC=N3)N4CCOCC4
Isomeric SMILES CN1C=C(C=C1C#N)C2=CNC3=C2C(=NC=N3)N4CCOCC4
PubChem CID 89915073
Molecular Weight 308.34

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilityDMSO : 10.42 mg/mL (33.79 mM; Need ultrasonic)

Safety and Hazards(GHS)

RIDADR NONHforallmodesoftransport

Related Documents

Solution Calculators